Detlev Mennerich - Profile and Investment Details

Investor Profile

Detlev Mennerich is a Corporate Venture Capital based in Bad Kreuznach, Rhineland-Palatinate, Germany with a diverse investment portfolio that includes companies such as Aignostics, T3 Pharmaceuticals, AUROBAC THERAPEUTICS, Dopavision, Topas Therapeutics, Actym, Topas Therapeutics GmbH, eTheRNA immunotherapies, STAT-Dx, Rinri Therapeutics, Rigontec, Hookipa Pharma, Tacalyx, NBE-Therapeutics, Synthetica Pioneering 生葆生物, Aelin Therapeutics, Okairos, ImCheck Therapeutics, Wellth, T-knife, Rinri Therapeutics Ltd., Brainomix, Tacalyx GmbH, Acousia Therapeutics, Rgenta Therapeutics, DiogenX, Cardior Pharmaceuticals, RiboX Therapeutics, HepaRegeniX GmbH, Delonix Bioworks, Bodyport, Ruipeng Pet Healthcare, Metabomed, ArmaGen Technologies, Rewind Therapeutics, HepaRegeniX, ViraTherapeutics GmbH, Perfood, Eyevensys, Advent France Biotechnology, Promethera Biosciences, Sentien Biotechnologies, Amal Therapeutics, Vira Therapeutics, OncoMyx Therapeutics, Libra Therapeutics, Abalos Therapeutics, NBE Therapeutics AGAgomAb Therapeutics, Boehringer Ingelheim Pharma GmbH & Co.KG, . Over time, Detlev Mennerich has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Detlev Mennerich is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Research and Development, Hospitals, Wellness, Women Founded, Healthcare Innovation, Chemical, Life Science, Artificial Intelligence (AI), Software, Manufacturing, Biotechnology, Drug Development, Cosmetics, Market Research, Innovation, Research, Health Diagnostics, Innovation Management, Digital Health, Renewable Energy, Medical, Information Technology, B2B, Therapeutics, Advanced Materials, Machine Learning, Personal Health, Pharmaceuticals, Oncology may find it worthwhile to explore potential connections with Detlev Mennerich, as their portfolio suggests a familiarity and interest in this area.

Understanding Detlev Mennerich’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.